Browse Category

Startups News 28 September 2025 - 29 October 2025

Wall Street’s High-Stakes Gamble: Kalshi’s $300 Million Raise Ignites Prediction Market Wars

Wall Street’s High-Stakes Gamble: Kalshi’s $300 Million Raise Ignites Prediction Market Wars

Kalshi’s $300 Million Cash Infusion and Rapid Ascent Kalshi’s latest funding round – over $300 million at a $5 billion valuation – marks one of the largest bets yet on the emerging prediction market industry tradingview.com. The startup, founded by young MIT graduates
10 October 2025
MEDIROM (NASDAQ: MRM) Set for Takeoff: Series A Boost & Altman-Backed ‘Orb’ Deal Fuels 150% Upside

MEDIROM (NASDAQ: MRM) Set for Takeoff: Series A Boost & Altman-Backed ‘Orb’ Deal Fuels 150% Upside

Company Background & Business Model MEDIROM Healthcare Technologies (NASDAQ: MRM) is a Tokyo‑based provider of holistic health and wellness services. Founded in 2000, it operates 300+ Re.Ra.Ku branded relaxation salons across Japan medirom.co.jp, offering massage, aromatherapy and lifestyle therapy. These
From Tennis Ball Launchers to Tokenized Equities: What Connexa Sports (YYAI) – Now AiRWA – Means for Investors in 2025

From Tennis Ball Launchers to Tokenized Equities: What Connexa Sports (YYAI) – Now AiRWA – Means for Investors in 2025

Stock Price & Recent Performance A micro‑cap stock in free‑fall After trading between $1 and $3 for much of August 2025, Connexa Sports’ share price crashed when it announced a $500 million joint‑venture with crypto exchange JuCoin to build the AiRWA
Mystery $75M Bet Propels POET Technologies – Tiny Optical Chipmaker Rides AI Gold Rush

Mystery $75M Bet Propels POET Technologies – Tiny Optical Chipmaker Rides AI Gold Rush

$75 Million Infusion Fuels AI Connectivity Expansion POET’s $75 million capital raise – a non-brokered private placement of ~13.64 million shares (with warrants) – marks a major vote of confidence in the company’s technology ts2.tech. “This is the largest single investment in POET’s
No-Revenue Biotech Soars 64,000% – Is Regencell (RGC) a Breakthrough or a Bubble?

No-Revenue Biotech Soars 64,000% – Is Regencell (RGC) a Breakthrough or a Bubble?

Company Profile and Mission Regencell Bioscience is an early-stage biotech company focused on Traditional Chinese Medicine. Headquartered in Causeway Bay, Hong Kong, Regencell researches, develops, and aims to commercialize herbal treatment formulae for neurocognitive disorders – primarily Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum
Vercel’s AI Breakthrough: $300M Raise Propels Developer Platform to $9.3B Valuation

Vercel’s AI Breakthrough: $300M Raise Propels Developer Platform to $9.3B Valuation

$300M Series F Round and $9.3B Valuation In late September 2025 Vercel announced a blockbuster Series F funding round that catapults the startup to a $9.3 billion valuation reuters.com bloomberg.com. The $300 million infusion was oversubscribed and co-led by VC
Go toTop